Multiple manufacturers recall leaky fentanyl patches
Transdermal fentanyl recalled by various manufacturers.
Actavis Inc. is recalling 14 lots of transdermal fentanyl due to a defect which may cause the patches to leak fentanyl gel outside the reservoir. No injuries have been reported; however, exposure to the gel could put patients and caregivers at risk for serious adverse events including respiratory depression and possible overdose. The affected Actavis recalling all 25 mcg/hr lots of Duragesic transdermal fentanyl systems and all lots of 25 mcg/hr fentanyl patches sold by Sandoz, Inc. for the same reason. The affected
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
